Issue 36, 2016

In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles

Abstract

A general strategy for image-guided prodrug activation using fluorescently-labeled magnetic iron oxide nanoparticles is described. It is based on a recently developed concept in bio-orthogonal inverse-electron demand Diels–Alder chemistry, which is termed ‘click-to-release’. To illustrate a potential new biomedical application of the chemistry, the nanoparticles were modified with tetrazine, as well as near infrared fluorescent (NIRF) cy5.5 dye, while doxorubicin was converted into a prodrug. The nanoparticles taken up by the MDA-MB-231 breast cancer cells efficiently converted the prodrug of doxorubicin into the biologically active chemotherapeutic doxorubicin form.

Graphical abstract: In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
01 Feb 2016
Accepted
01 Apr 2016
First published
01 Apr 2016

Chem. Commun., 2016,52, 6174-6177

In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles

I. Khan, P. F. Agris, M. V. Yigit and M. Royzen, Chem. Commun., 2016, 52, 6174 DOI: 10.1039/C6CC01024E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements